RU2009128067A - Варианты липаз для их применения в фармацевтике - Google Patents
Варианты липаз для их применения в фармацевтике Download PDFInfo
- Publication number
- RU2009128067A RU2009128067A RU2009128067/10A RU2009128067A RU2009128067A RU 2009128067 A RU2009128067 A RU 2009128067A RU 2009128067/10 A RU2009128067/10 A RU 2009128067/10A RU 2009128067 A RU2009128067 A RU 2009128067A RU 2009128067 A RU2009128067 A RU 2009128067A
- Authority
- RU
- Russia
- Prior art keywords
- lipase
- seq
- sequence
- amylase
- protease
- Prior art date
Links
- 239000004367 Lipase Substances 0.000 title claims abstract 76
- 102000004882 Lipase Human genes 0.000 title claims abstract 76
- 108090001060 Lipase Proteins 0.000 title claims abstract 76
- 235000019421 lipase Nutrition 0.000 title claims abstract 76
- 238000006467 substitution reaction Methods 0.000 claims abstract 20
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract 19
- 235000019626 lipase activity Nutrition 0.000 claims abstract 13
- 238000000034 method Methods 0.000 claims abstract 12
- 102000057297 Pepsin A Human genes 0.000 claims abstract 10
- 108090000284 Pepsin A Proteins 0.000 claims abstract 10
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract 10
- 229940111202 pepsin Drugs 0.000 claims abstract 10
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract 10
- 239000003814 drug Substances 0.000 claims abstract 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 8
- 238000007792 addition Methods 0.000 claims abstract 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 7
- 238000003776 cleavage reaction Methods 0.000 claims abstract 7
- 230000007017 scission Effects 0.000 claims abstract 7
- 102220479102 CD59 glycoprotein_N33Q_mutation Human genes 0.000 claims abstract 6
- 210000004051 gastric juice Anatomy 0.000 claims abstract 6
- 238000000338 in vitro Methods 0.000 claims abstract 6
- 238000002156 mixing Methods 0.000 claims abstract 5
- 102220204637 rs137852883 Human genes 0.000 claims abstract 5
- 102220033643 rs8069375 Human genes 0.000 claims abstract 5
- 102220536901 PRKC apoptosis WT1 regulator protein_L69I_mutation Human genes 0.000 claims abstract 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims abstract 3
- 239000000872 buffer Substances 0.000 claims abstract 3
- 102220360655 c.170A>G Human genes 0.000 claims abstract 3
- 238000011534 incubation Methods 0.000 claims abstract 3
- 102200158812 rs104894225 Human genes 0.000 claims abstract 3
- 102220008213 rs116840785 Human genes 0.000 claims abstract 3
- 102220082775 rs144148008 Human genes 0.000 claims abstract 3
- 102220057725 rs374836770 Human genes 0.000 claims abstract 3
- 102220045389 rs587782063 Human genes 0.000 claims abstract 3
- 102220330013 rs78488639 Human genes 0.000 claims abstract 3
- 102220020884 rs80356880 Human genes 0.000 claims abstract 3
- 102200114143 rs9282858 Human genes 0.000 claims abstract 3
- 239000001632 sodium acetate Substances 0.000 claims abstract 3
- 235000017281 sodium acetate Nutrition 0.000 claims abstract 3
- 102220515651 Insulin-like growth factor I_R84E_mutation Human genes 0.000 claims abstract 2
- 102220536108 Serine/threonine-protein kinase OSR1_K46M_mutation Human genes 0.000 claims abstract 2
- 102220600976 Syndecan-4_N26A_mutation Human genes 0.000 claims abstract 2
- 101150025207 VPK2 gene Proteins 0.000 claims abstract 2
- 101100049497 Variola virus (isolate Human/India/Ind3/1967) C14L gene Proteins 0.000 claims abstract 2
- 102200080817 rs104894869 Human genes 0.000 claims abstract 2
- 102220059022 rs786201869 Human genes 0.000 claims abstract 2
- 102220028139 rs80357084 Human genes 0.000 claims abstract 2
- 230000028327 secretion Effects 0.000 claims abstract 2
- 239000004382 Amylase Substances 0.000 claims 20
- 102000013142 Amylases Human genes 0.000 claims 20
- 108010065511 Amylases Proteins 0.000 claims 20
- 102000035195 Peptidases Human genes 0.000 claims 20
- 108091005804 Peptidases Proteins 0.000 claims 20
- 239000004365 Protease Substances 0.000 claims 20
- 235000019418 amylase Nutrition 0.000 claims 20
- 150000001413 amino acids Chemical class 0.000 claims 17
- 239000000203 mixture Substances 0.000 claims 7
- 239000003833 bile salt Substances 0.000 claims 6
- 229940093761 bile salts Drugs 0.000 claims 6
- 229920004890 Triton X-100 Polymers 0.000 claims 5
- 230000000694 effects Effects 0.000 claims 4
- 201000003883 Cystic fibrosis Diseases 0.000 claims 3
- 206010033645 Pancreatitis Diseases 0.000 claims 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 3
- 230000001079 digestive effect Effects 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 201000007089 exocrine pancreatic insufficiency Diseases 0.000 claims 3
- 235000021588 free fatty acids Nutrition 0.000 claims 3
- 239000000758 substrate Substances 0.000 claims 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 3
- 102220584273 Cellular tumor antigen p53_E56K_mutation Human genes 0.000 claims 2
- 102220564804 Killer cell immunoglobulin-like receptor 2DL2_N73D_mutation Human genes 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000007983 Tris buffer Substances 0.000 claims 2
- 239000003613 bile acid Substances 0.000 claims 2
- 102220412429 c.297A>C Human genes 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 102220276634 rs1553131563 Human genes 0.000 claims 2
- 102220277043 rs1553408229 Human genes 0.000 claims 2
- 102220104423 rs63749907 Human genes 0.000 claims 2
- 102220104592 rs879254078 Human genes 0.000 claims 2
- 102220105300 rs879254420 Human genes 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 2
- 102220598657 5-hydroxytryptamine receptor 1E_D27R_mutation Human genes 0.000 claims 1
- 102220473558 ADP-ribosylation factor-like protein 2-binding protein_E56A_mutation Human genes 0.000 claims 1
- 102220524143 Cadherin-24_N26I_mutation Human genes 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 102220568523 Clustered mitochondria protein homolog_E99S_mutation Human genes 0.000 claims 1
- 102220644676 Galectin-related protein_D96L_mutation Human genes 0.000 claims 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 claims 1
- 102220517768 Methyl-CpG-binding domain protein 3-like 2B_D27Y_mutation Human genes 0.000 claims 1
- 102220500768 Protein N-lysine methyltransferase METTL21D_D96V_mutation Human genes 0.000 claims 1
- 102220616017 Sterile alpha motif domain-containing protein 5_D96Y_mutation Human genes 0.000 claims 1
- 102220593678 Stromal interaction molecule 1_E87Q_mutation Human genes 0.000 claims 1
- 102220496421 Zinc finger CCHC domain-containing protein 24_E43V_mutation Human genes 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 231100000673 dose–response relationship Toxicity 0.000 claims 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims 1
- 229940049964 oleate Drugs 0.000 claims 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 102200161847 rs104894126 Human genes 0.000 claims 1
- 102200121669 rs104894915 Human genes 0.000 claims 1
- 102200006121 rs1060501260 Human genes 0.000 claims 1
- 102200014825 rs113203706 Human genes 0.000 claims 1
- 102200128615 rs121908750 Human genes 0.000 claims 1
- 102220312400 rs1555802310 Human genes 0.000 claims 1
- 102200068777 rs1805005 Human genes 0.000 claims 1
- 102200097285 rs199473487 Human genes 0.000 claims 1
- 102220271537 rs200383861 Human genes 0.000 claims 1
- 102220041065 rs200979664 Human genes 0.000 claims 1
- 102200108133 rs201753350 Human genes 0.000 claims 1
- 102220097791 rs201753350 Human genes 0.000 claims 1
- 102200110982 rs28931568 Human genes 0.000 claims 1
- 102200028671 rs3765620 Human genes 0.000 claims 1
- 102200027496 rs63751429 Human genes 0.000 claims 1
- 102200101939 rs72554338 Human genes 0.000 claims 1
- 102220056648 rs730881059 Human genes 0.000 claims 1
- 102220052839 rs73113102 Human genes 0.000 claims 1
- 102220084740 rs767734253 Human genes 0.000 claims 1
- 102200116704 rs77587352 Human genes 0.000 claims 1
- 102200058234 rs80338731 Human genes 0.000 claims 1
- 102220087418 rs864622444 Human genes 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 102220468054 Brother of CDO_N73Q_mutation Human genes 0.000 abstract 1
- 102220623143 Protein DGCR6_E87A_mutation Human genes 0.000 abstract 1
- 102220358508 c.297A>T Human genes 0.000 abstract 1
- 102200163576 rs28929478 Human genes 0.000 abstract 1
- 102220020411 rs397508256 Human genes 0.000 abstract 1
- 102220244268 rs550027484 Human genes 0.000 abstract 1
- 102220077759 rs797045050 Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87119606P | 2006-12-21 | 2006-12-21 | |
| US60/871,196 | 2006-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2009128067A true RU2009128067A (ru) | 2011-01-27 |
Family
ID=38043020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009128067/10A RU2009128067A (ru) | 2006-12-21 | 2007-12-12 | Варианты липаз для их применения в фармацевтике |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US8273348B2 (cg-RX-API-DMAC7.html) |
| EP (6) | EP2455460A3 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5406040B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090101930A (cg-RX-API-DMAC7.html) |
| CN (2) | CN101743308B (cg-RX-API-DMAC7.html) |
| AR (1) | AR064494A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007337150A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0721103A2 (cg-RX-API-DMAC7.html) |
| CA (3) | CA2670643C (cg-RX-API-DMAC7.html) |
| IL (1) | IL198893A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009006597A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20092729L (cg-RX-API-DMAC7.html) |
| RU (1) | RU2009128067A (cg-RX-API-DMAC7.html) |
| TW (1) | TW200829698A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008079685A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200903598B (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110462037A (zh) * | 2017-01-30 | 2019-11-15 | 学校法人日本医科大学 | 腺相关病毒(aav)衣壳蛋白的突变体 |
| RU2712877C2 (ru) * | 2013-05-14 | 2020-01-31 | Новозимс А/С | Моющие композиции |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2381813C2 (ru) | 2004-03-22 | 2010-02-20 | Зольвай Фармасьютиклз Гмбх | Пероральные фармацевтические композиции на основе продуктов, содержащих липазы, прежде всего панкреатин, и пав |
| CA2616943C (en) | 2005-07-29 | 2016-04-12 | Solvay Pharmaceuticals Gmbh | Processes for the manufacture of sterilized pancreatin powder |
| US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
| US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
| US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
| EP2455460A3 (en) * | 2006-12-21 | 2012-12-26 | Novozymes A/S | Lipase variants for pharmaceutical use |
| EP2250258B1 (en) * | 2008-02-29 | 2017-01-04 | Novozymes A/S | Lipolytic enzyme variant with improved stability and polynucleotides encoding same |
| JP2011513539A (ja) * | 2008-02-29 | 2011-04-28 | ザ プロクター アンド ギャンブル カンパニー | リパーゼを含む洗剤組成物 |
| DK2254996T3 (da) | 2008-02-29 | 2013-10-07 | Dsm Ip Assets Bv | Lipaser med høj specificitet for kortkædede fedtsyrer og anvendelser deraf |
| WO2011072117A1 (en) | 2009-12-09 | 2011-06-16 | The Procter & Gamble Company | Fabric and home care products |
| CN109022518A (zh) | 2011-07-22 | 2018-12-18 | 诺维信北美公司 | 用于预处理纤维素材料和改进其水解的方法 |
| US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
| CN110777016A (zh) * | 2011-12-29 | 2020-02-11 | 诺维信公司 | 具有脂肪酶变体的洗涤剂组合物 |
| CN108148823B (zh) * | 2012-02-03 | 2023-03-14 | 诺维信公司 | 脂肪酶变体以及编码它们的多核苷酸 |
| EP2834353B1 (en) * | 2012-04-02 | 2017-07-19 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
| EP2906691B1 (en) * | 2012-10-12 | 2021-01-27 | Danisco US Inc. | Compositions and methods comprising a lipolytic enzyme variant |
| EP3022299B1 (en) * | 2013-07-19 | 2020-03-18 | Danisco US Inc. | Compositions and methods comprising a lipolytic enzyme variant |
| CN107075489A (zh) * | 2014-11-20 | 2017-08-18 | 诺维信公司 | 脂环酸芽孢杆菌变体以及编码它们的多核苷酸 |
| EP4067485A3 (en) * | 2014-12-05 | 2023-01-04 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
| EP3230442B1 (en) * | 2014-12-09 | 2019-05-22 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
| US20180355404A1 (en) | 2015-04-07 | 2018-12-13 | Novozymes A/S | Methods for selecting enzymes having lipase activity |
| EP3929285A3 (en) * | 2015-07-01 | 2022-05-25 | Novozymes A/S | Methods of reducing odor |
| WO2017005640A1 (en) * | 2015-07-03 | 2017-01-12 | Novozymes A/S | Detergent compositions with improved stability in the presence of sulfites |
| US11326152B2 (en) * | 2016-07-18 | 2022-05-10 | Novozymes A/S | Lipase variants, polynucleotides encoding same and the use thereof |
| US11286443B2 (en) * | 2017-09-27 | 2022-03-29 | The Procter & Gamble Company | Detergent compositions comprising lipases |
| CA3073362A1 (en) | 2017-09-27 | 2019-04-04 | Novozymes A/S | Lipase variants and microcapsule compositions comprising such lipase variants |
| CN111801416A (zh) * | 2018-02-08 | 2020-10-20 | 诺维信公司 | 脂肪酶变体及其组合物 |
| US12269847B2 (en) * | 2018-08-16 | 2025-04-08 | Donaldson Company, Inc. | Genetically encoded polypeptide for affinity capture and purification of biologics |
| CN111334369B (zh) * | 2020-03-11 | 2022-10-21 | 陕西科技大学 | 一种酶法制备卵磷脂型pufa的方法 |
| EP4172325A1 (en) * | 2020-06-24 | 2023-05-03 | Cilian AG | New lipase enzyme |
| US20240035005A1 (en) * | 2020-10-29 | 2024-02-01 | Novozymes A/S | Lipase variants and compositions comprising such lipase variants |
| CN113846074B (zh) * | 2021-10-20 | 2022-10-21 | 南京林业大学 | 一种疏棉状嗜热丝孢菌脂肪酶突变体g91c及其应用 |
| US20250311734A1 (en) | 2022-05-14 | 2025-10-09 | Novozymes A/S | Compositions and Methods for Preventing, Treating, Suppressing and/or Eliminatting Phytopathogenic Infestations and Infections |
| CN119522274A (zh) * | 2022-06-24 | 2025-02-25 | 诺维信公司 | 脂肪酶变体和包含这样的脂肪酶变体的组合物 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK173590D0 (da) | 1990-06-06 | 1990-07-19 | Novo Nordisk As | Rekombinante terapeutiske lipaser |
| AU657278B2 (en) | 1990-09-13 | 1995-03-09 | Novo Nordisk A/S | Lipase variants |
| DK46693D0 (cg-RX-API-DMAC7.html) * | 1993-04-23 | 1993-04-23 | Novo Nordisk As | |
| US5869438A (en) | 1990-09-13 | 1999-02-09 | Novo Nordisk A/S | Lipase variants |
| WO1992010755A1 (en) | 1990-12-05 | 1992-06-25 | Novo Nordisk A/S | Proteins with changed epitopes and methods for the production thereof |
| EP0585285B1 (en) | 1991-05-01 | 1998-08-12 | Novo Nordisk A/S | Stabilized enzymes |
| DK39693D0 (da) | 1993-04-02 | 1993-04-02 | Novo Nordisk As | Enzym |
| BR9407752A (pt) | 1993-10-04 | 1997-03-04 | Novo Nordisk As | Preparaçao de enzima aditivo detergente composiçao detergente processo para o tratamento de fibras lignocelulósicas |
| AU1806795A (en) * | 1994-02-22 | 1995-09-04 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
| EP0793726A1 (en) | 1994-11-24 | 1997-09-10 | Novo Nordisk A/S | A process for producing polypeptides with reduced allergenicity |
| FI972443L (fi) | 1994-12-07 | 1997-06-09 | Novo Nordisk As | Polypeptidi, jonka allergeenisuus on vähentynyt |
| CA2209617C (en) | 1995-01-26 | 2002-05-28 | Novo Nordisk A/S | Animal feed additives comprising xylanase |
| US6495357B1 (en) * | 1995-07-14 | 2002-12-17 | Novozyme A/S | Lipolytic enzymes |
| ATE282087T1 (de) | 1995-07-14 | 2004-11-15 | Novozymes As | Modifiziertes enzym mit lipolytischer aktivität |
| ATE267248T1 (de) | 1995-08-11 | 2004-06-15 | Novozymes As | Neuartige lipolytische enzyme |
| EP0954572A1 (en) | 1997-01-10 | 1999-11-10 | Novo Nordisk A/S | Enzyme coupled with polymeric molecules for skin care |
| AU740207B2 (en) | 1997-02-06 | 2001-11-01 | Novozymes A/S | Polypeptide-polymer conjugates having added and/or removed attachment groups |
| DK1002064T3 (da) | 1997-06-25 | 2008-02-04 | Novozymes As | Modificeret polypeptid |
| ATE328070T1 (de) * | 1998-02-17 | 2006-06-15 | Novozymes As | Lipasevariante |
| AU3247699A (en) | 1998-02-17 | 1999-09-06 | Novo Nordisk A/S | Lipase variant |
| JP2002527059A (ja) | 1998-10-13 | 2002-08-27 | ノボザイムス アクティーゼルスカブ | 低められた免疫応答を有する修飾されたポリペプチド |
| CA2348938A1 (en) | 1998-10-30 | 2000-05-11 | Novozymes A/S | Low allergenic protein variants |
| ATE365210T1 (de) * | 1998-10-30 | 2007-07-15 | Novozymes As | Glykosylierte proteine mit reduzierter allergenität |
| US7312062B2 (en) * | 1998-11-27 | 2007-12-25 | Novozymes A/S | Lipolytic enzyme variants |
| WO2000032758A1 (en) | 1998-11-27 | 2000-06-08 | Novozymes A/S | Lipolytic enzyme variants |
| ES2194720T3 (es) | 1999-03-17 | 2003-12-01 | Solvay Pharm Gmbh | Enzimas para el tratamiento de diabetes mellitus tipo i. |
| MXPA01009700A (es) * | 1999-03-31 | 2002-05-14 | Novo Nordisk As | Variante de lipasa. |
| DK1428874T3 (en) * | 1999-03-31 | 2014-03-10 | Novozymes As | lipase variant |
| WO2001058275A2 (en) | 2000-02-08 | 2001-08-16 | F Hoffmann-La Roche Ag | Use of acid-stable subtilisin proteases in animal feed |
| EP2258852A1 (en) * | 2000-04-28 | 2010-12-08 | Novozymes A/S | Lipolytic enzyme variant |
| ES2323947T3 (es) * | 2001-01-10 | 2009-07-28 | Novozymes A/S | Variante de enzima lipolitica. |
| AR032392A1 (es) | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
| EP1360278B1 (en) | 2001-02-07 | 2009-09-23 | Novozymes A/S | Lipase variants |
| AU2003203139B2 (en) * | 2002-01-16 | 2007-11-08 | Novozymes A/S | Lipolytic enzyme variants and method for their production |
| AU2004208860A1 (en) | 2003-02-06 | 2004-08-19 | Novozymes A/S | Human heavy chain antibody expression in filamentous fungi |
| CA2523400C (en) * | 2003-05-09 | 2015-03-17 | Novozymes A/S | Variant lipolytic enzymes |
| WO2004111224A1 (en) | 2003-06-19 | 2004-12-23 | Novozymes A/S | Improved proteases and methods for producing them |
| US20060251763A1 (en) | 2003-06-19 | 2006-11-09 | Patkar Shamkant A | Phospholipase variants |
| AR047440A1 (es) | 2004-01-21 | 2006-01-18 | Novozymes As | Produccion de un anticuerpo monoclonal en un hongo heterocarion o una celula huesped fungal |
| RU2381813C2 (ru) | 2004-03-22 | 2010-02-20 | Зольвай Фармасьютиклз Гмбх | Пероральные фармацевтические композиции на основе продуктов, содержащих липазы, прежде всего панкреатин, и пав |
| DE602005022471D1 (de) | 2004-10-14 | 2010-09-02 | Altus Pharmaceuticals Inc | Zusammensetzungen enthaltend lipase, protease und amylase zur behandlung von pankreasinsuffizienz |
| US20080138856A1 (en) | 2005-02-10 | 2008-06-12 | Novozymes A/S | Enzymatic Enantioselective Ester or Amide Hydrolysis or Synthesis |
| MX2007015472A (es) * | 2005-06-24 | 2008-04-17 | Novozymes As | Lipasas para uso farmaceutico. |
| CA2612811A1 (en) | 2005-06-24 | 2006-12-28 | Novozymes A/S | Amylases for pharmaceutical use |
| AU2006261443A1 (en) | 2005-06-24 | 2006-12-28 | Novozymes A/S | Proteases for pharmaceutical use |
| WO2007080197A2 (en) * | 2006-01-16 | 2007-07-19 | Novozymes A/S | Immobilised enzymes |
| AR059154A1 (es) * | 2006-01-23 | 2008-03-12 | Procter & Gamble | Una composicion que comprende una lipasa y un catalizador de blanqueador |
| BRPI0707202A2 (pt) * | 2006-01-23 | 2011-04-26 | Novozymes Inc | variante, seqüência de dna, vetor de expresseão, célula hospedeira transformada, e, método de produzir uma variante de lìpase |
| EP2455460A3 (en) * | 2006-12-21 | 2012-12-26 | Novozymes A/S | Lipase variants for pharmaceutical use |
-
2007
- 2007-12-12 EP EP12155315A patent/EP2455460A3/en not_active Withdrawn
- 2007-12-12 CA CA2670643A patent/CA2670643C/en active Active
- 2007-12-12 MX MX2009006597A patent/MX2009006597A/es not_active Application Discontinuation
- 2007-12-12 US US12/519,868 patent/US8273348B2/en active Active
- 2007-12-12 EP EP12155319.2A patent/EP2455462B1/en active Active
- 2007-12-12 EP EP12155317.6A patent/EP2455461B1/en active Active
- 2007-12-12 CN CN200780051638.6A patent/CN101743308B/zh active Active
- 2007-12-12 KR KR1020097014850A patent/KR20090101930A/ko not_active Withdrawn
- 2007-12-12 CN CN201510504893.8A patent/CN105112386A/zh active Pending
- 2007-12-12 EP EP07869130A patent/EP2099907A2/en not_active Withdrawn
- 2007-12-12 EP EP10172609.9A patent/EP2261328B1/en active Active
- 2007-12-12 CA CA3081308A patent/CA3081308C/en active Active
- 2007-12-12 AU AU2007337150A patent/AU2007337150A1/en not_active Abandoned
- 2007-12-12 EP EP12155294.7A patent/EP2455459B1/en active Active
- 2007-12-12 RU RU2009128067/10A patent/RU2009128067A/ru not_active Application Discontinuation
- 2007-12-12 BR BRPI0721103-1A patent/BRPI0721103A2/pt not_active IP Right Cessation
- 2007-12-12 CA CA2961041A patent/CA2961041C/en active Active
- 2007-12-12 JP JP2009543078A patent/JP5406040B2/ja active Active
- 2007-12-12 WO PCT/US2007/087168 patent/WO2008079685A2/en not_active Ceased
- 2007-12-18 TW TW096148377A patent/TW200829698A/zh unknown
- 2007-12-21 AR ARP070105859A patent/AR064494A1/es not_active Application Discontinuation
-
2009
- 2009-05-21 IL IL198893A patent/IL198893A0/en unknown
- 2009-05-25 ZA ZA200903598A patent/ZA200903598B/xx unknown
- 2009-07-20 NO NO20092729A patent/NO20092729L/no not_active Application Discontinuation
-
2012
- 2012-08-16 US US13/587,043 patent/US9029115B2/en active Active
-
2015
- 2015-04-06 US US14/679,563 patent/US9539311B2/en active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2712877C2 (ru) * | 2013-05-14 | 2020-01-31 | Новозимс А/С | Моющие композиции |
| US12116601B2 (en) | 2013-05-14 | 2024-10-15 | Novozymes A/S | Detergent compositions |
| CN110462037A (zh) * | 2017-01-30 | 2019-11-15 | 学校法人日本医科大学 | 腺相关病毒(aav)衣壳蛋白的突变体 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009128067A (ru) | Варианты липаз для их применения в фармацевтике | |
| Stafforini et al. | Mammalian platelet-activating factor acetylhydrolases | |
| Martinez et al. | Cutinase, a lipolytic enzyme with a preformed oxyanion hole | |
| Maraganore et al. | A new class of phospholipases A2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding. | |
| Arai et al. | Platelet-activating factor acetylhydrolase (PAF-AH) | |
| Baker | Is vitellogenin an ancestor of apolipoprotein B-100 of human low-density lipoprotein and human lipoprotein lipase? | |
| Thirstrup et al. | Evidence for a pancreatic lipase subfamily with new kinetic properties | |
| Rypniewski et al. | Evolutionary divergence and conservation of trypsin | |
| Gerber-Huber et al. | Precursor-product relationship between vitellogenin and the yolk proteins as derived from the complete sequence of a Xenopus vitellogenin gene | |
| AU645583B2 (en) | Recombinantly produced lipases for therapeutical treatment | |
| Nevinsky et al. | Natural catalytic antibodies (abzymes) in normalcy and pathology | |
| CN101208429A (zh) | 用于药物用途的脂肪酶 | |
| Inaba et al. | Purification of proteasomes from salmonid fish sperm and their localization along sperm flagella | |
| Fujihara et al. | Comparative biochemical properties of vertebrate deoxyribonuclease I | |
| JPH08508399A (ja) | ホスホリパーゼ及びヒアルロニダーゼのようなスズメバチ毒酵素のクローニング及び組換え体の生産並びにそれに基づく免疫学的治療 | |
| Teo et al. | Cloning and characterization of a novel lipase from Vibrio harveyi strain AP6 | |
| Hilton et al. | Purification and spectral study of a microbial fatty acyltransferase: activation by limited proteolysis | |
| Andryushkova et al. | Nucleotide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice | |
| Liberio et al. | The crude skin secretion of the pepper frog Leptodactylus labyrinthicus is rich in metallo and serine peptidases | |
| Guo et al. | Purification, characterization, and cDNA cloning of a myofibril-bound serine proteinase from the skeletal muscle of crucian carp (Carassius auratus) | |
| Zarai et al. | Purification and biochemical properties of Hexaplex trunculus digestive lipase | |
| Yamada et al. | Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes. | |
| Wang et al. | Transcriptome analysis of different life-history stages and screening of male-biased genes in Daphnia sinensis | |
| Lu et al. | Identification of essential residues for catalysis of rat intestinal phospholipase B/lipase | |
| Kageyama | Role of S ‘1 loop residues in the substrate specificities of pepsin A and chymosin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20120110 |